跳至主要内容
临床试验/JPRN-UMIN000038881
JPRN-UMIN000038881招募中未知

The effects of denosumab compared with alendronate on glucocorticoid-induced osteoporosis in patients with malignant lymphoma - DENOSULY trial

Toyama University Hospital Department of Hematology0 个研究点目标入组 100 人开始时间: 2020年1月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with a history of hypersensitivity to any component of denosumab Patients with hypocalcemia Patients who are pregnant and who may be pregnant Patients with a condition that makes swallowing difficult such as stenosis and achalasia of esophagus Patients unable to sit upright or stand more than thirty minutes Patients with a history of hypersensitivity to bisphosphonates Patients with hypercalcemia or hypervitaminosis D Patients who are on osteoporotic treatment with denosumab or bisphosphonates Patients thought to be inappropriate for this study by physician

研究者

发起方
Toyama University Hospital Department of Hematology

相似试验